Qilian International Holding Group Limited logo
Qilian International Holding Group Limited QLI

Annual report 2021
added 10-13-2022

report update icon

Qilian International Holding Group Limited Operating Expenses 2011-2026 | QLI

Annual Operating Expenses Qilian International Holding Group Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 2.16 M 2.25 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.25 M 2.16 M 2.21 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer Operating Expenses Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
432 M - 2.43 % $ 254 M germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
24.2 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
1.49 B - - $ 866 M chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
4.78 M - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
2.66 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
78.3 M - 2.54 % $ 160 B franceFrance
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
8.22 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
18.7 M - - $ 269 M usaUSA
BioNTech SE BioNTech SE
BNTX
512 M - - $ 27.2 B germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
629 M - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
61.5 M - - $ 231 M usaUSA
INmune Bio INmune Bio
INMB
47.4 M $ 1.52 -1.3 % $ 37.6 M usaUSA
Exelixis Exelixis
EXEL
598 M $ 48.7 9.64 % $ 13.2 B usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
708 M $ 21.48 -3.89 % $ 3.56 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
125 M - - $ 71.1 M usaUSA
Advaxis Advaxis
ADXS
22 M - -9.65 % $ 45.9 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
343 M $ 3.15 1.19 % $ 655 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
14 M - - $ 5.51 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
13.3 M - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
210 M - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
88.9 M - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
66.5 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
179 M - 1.93 % $ 17.4 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
80.2 M - - $ 3.67 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
24.7 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
62.6 M - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
86.8 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
163 M - -0.23 % $ 916 M usaUSA
Allakos Allakos
ALLK
196 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
46.2 M - 4.14 % $ 49.1 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
137 M $ 24.17 3.2 % $ 3.08 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
47.6 M - 3.16 % $ 1.9 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
9.57 M - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
127 M - - $ 10.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
88.2 M - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
50.6 M - 10.36 % $ 9.8 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
74.5 M - - $ 8.42 M usaUSA
Aravive Aravive
ARAV
80 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
23.4 K - 17.91 % $ 11.1 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
668 M $ 55.08 5.15 % $ 4.95 B schweizSchweiz
Avenue Therapeutics Avenue Therapeutics
ATXI
4.49 M - -52.27 % $ 4.45 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
145 M $ 1.7 3.66 % $ 452 M britainBritain
AVROBIO AVROBIO
AVRO
71.7 M - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
29.8 M - - $ 7.46 M israelIsrael
Завод ДИОД Завод ДИОД
DIOD
249 M - - - russiaRussia
Фармсинтез Фармсинтез
LIFE
201 M - - - russiaRussia
AstraZeneca PLC AstraZeneca PLC
AZN
17.6 B - - $ 96.9 B britainBritain
Galapagos NV Galapagos NV
GLPG
709 M $ 28.81 1.48 % $ 2.69 B belgiumBelgium
Genmab A/S Genmab A/S
GMAB
67.9 M $ 27.89 1.34 % $ 17.2 B danmarkDanmark